Neovii Pharmaceuticals Appoints Salvatore Alesci as Chief Medical Officer
PRIVATEOct 22, 2026
Position
Chief Medical Officer
Company
Neovii
Salvatore Alesci
Rapperswil JonaBiotechnologyHealth Care
Description
Neovii Pharmaceuticals AG has appointed physician-scientist Salvatore Alesci as Chief Medical Officer effective October 15, 2026. Dr. Alesci will lead clinical development as the company expands into immune-mediated diseases.
Who to call at Neovii, and when
A new leader at Neovii brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Neovii raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Neovii, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Neovii
Location
Rapperswil Jona, St. Gallen, Switzerland
About
Neovii is a global leader in polyclonal antibody immunosuppressive therapy used in organ transplantation and hematology/oncology.
Our lead product, Grafalon®, has been used for over 30 years to treat patients and is available in more than 40 countries world wide. It has approval for use in immunosuppressive therapies for prevention of graft- versus- host disease in stem cell transplantation, prevention and treatment of rejection in solid organ transplantation and in treatment of aplastic anemia.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neovii changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Rapperswil JonaBiotechnologyHealth Care